JP2024535880A5 - - Google Patents
Info
- Publication number
- JP2024535880A5 JP2024535880A5 JP2024517408A JP2024517408A JP2024535880A5 JP 2024535880 A5 JP2024535880 A5 JP 2024535880A5 JP 2024517408 A JP2024517408 A JP 2024517408A JP 2024517408 A JP2024517408 A JP 2024517408A JP 2024535880 A5 JP2024535880 A5 JP 2024535880A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- pharmaceutical product
- product according
- agent
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163246755P | 2021-09-21 | 2021-09-21 | |
| US63/246,755 | 2021-09-21 | ||
| PCT/US2022/044003 WO2023049075A1 (en) | 2021-09-21 | 2022-09-19 | Ibudilast in combination therapy for use in the treatment of glioblastoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535880A JP2024535880A (ja) | 2024-10-02 |
| JP2024535880A5 true JP2024535880A5 (enExample) | 2025-09-25 |
Family
ID=83688651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517408A Pending JP2024535880A (ja) | 2021-09-21 | 2022-09-19 | 膠芽腫の治療における使用のための併用療法におけるイブジラスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230090534A1 (enExample) |
| EP (1) | EP4404928A1 (enExample) |
| JP (1) | JP2024535880A (enExample) |
| CN (1) | CN118139619A (enExample) |
| CA (1) | CA3231869A1 (enExample) |
| WO (1) | WO2023049075A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024528731A (ja) | 2021-07-26 | 2024-07-30 | メディシノバ・インコーポレイテッド | 眼癌転移を予防するためのイブジラスト |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8562198A (en) | 1998-08-10 | 2000-03-06 | Kyorin Pharmaceutical Co. Ltd. | Remedies for multiple sclerosis |
| WO2006063048A2 (en) | 2004-12-06 | 2006-06-15 | Avigen, Inc. | Ibudilast for treating neuropathic pain and associated syndromes |
| CA2693697C (en) | 2007-07-11 | 2017-07-25 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| EP3043819A4 (en) * | 2013-09-11 | 2017-04-05 | Compugen Ltd. | Anti-vstm5 antibodies and the use thereof in therapy and diagnosis |
| EP3558301A4 (en) * | 2016-12-22 | 2020-07-29 | MediciNova, Inc. | METHOD FOR TREATING GLIOBLASTOMA MULTIFORME WITH IBUDILAST |
| CN110914302A (zh) * | 2017-06-01 | 2020-03-24 | 赛托姆克斯治疗学股份有限公司 | 可活化抗pdl1抗体及其使用方法 |
| CA3090884A1 (en) * | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
| WO2020028134A1 (en) * | 2018-07-30 | 2020-02-06 | Fred Hutchinson Cancer Research Center | Methods and compositions for treating cancer |
-
2022
- 2022-09-19 CA CA3231869A patent/CA3231869A1/en active Pending
- 2022-09-19 WO PCT/US2022/044003 patent/WO2023049075A1/en not_active Ceased
- 2022-09-19 EP EP22786655.5A patent/EP4404928A1/en active Pending
- 2022-09-19 JP JP2024517408A patent/JP2024535880A/ja active Pending
- 2022-09-19 CN CN202280068158.5A patent/CN118139619A/zh active Pending
- 2022-09-19 US US17/947,560 patent/US20230090534A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chiang et al. | Recurrent aphthous stomatitis–Etiology, serum autoantibodies, anemia, hematinic deficiencies, and management | |
| US11826317B2 (en) | Combination therapy with notch and PD-1 or PD-L1 inhibitors | |
| Ruocco et al. | Pemphigus: associations and management guidelines: facts and controversies | |
| Piscitelli et al. | Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers | |
| KR20240056564A (ko) | T 세포 림프종을 치료하기 위한 약물을 제조하는 데 있어서 ezh2 억제제의 용도 | |
| Ishiguro et al. | Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014–2015 to 2016–2017 influenza seasons in Japan | |
| JP2019526595A5 (enExample) | ||
| JP2020500152A5 (enExample) | ||
| HRP20100014T1 (hr) | Uporaba il-23 i il-17 antagonista u liječenju autoimune očne upalne bolesti | |
| FI3519049T3 (fi) | Turvallinen ja tehokas menetelmä psoriaasin hoitamiseen il23- spesifisellä vasta-aineella | |
| CA2802853A1 (en) | Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation | |
| TW202214242A (zh) | 西奧羅尼或其衍生物在製備用於預防和/或治療非霍奇金淋巴瘤的藥物之用途 | |
| JP2020502261A5 (enExample) | ||
| Wu et al. | Managing strategies of chemotherapy and radiotherapy-induced oral mucositis | |
| JP2022523045A5 (enExample) | ||
| JP2024016209A5 (enExample) | ||
| CN104039148A (zh) | 组合als疗法 | |
| CN114980876A (zh) | 用艾拉菲诺治疗原发性胆汁性胆管炎 | |
| JP2023524359A5 (enExample) | ||
| KR20050083762A (ko) | 반응성 관절염 또는 활액낭염의 치료 | |
| JP2025511402A5 (enExample) | ||
| Luqmani | Discontinuation of therapies in vasculitis | |
| JP2024512558A5 (enExample) | ||
| US20140127295A1 (en) | Compositions, process of preparation of said compositions and method of treating inflammatory diseases | |
| He et al. | Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis |